Hims & Hers Health Revenue 2020-2025 | HIMS
Hims & Hers Health annual/quarterly revenue history and growth rate from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Hims & Hers Health revenue for the quarter ending September 30, 2025 was $0.599B, a 49.16% increase year-over-year.
- Hims & Hers Health revenue for the twelve months ending September 30, 2025 was $2.211B, a 78.02% increase year-over-year.
- Hims & Hers Health annual revenue for 2024 was $1.477B, a 69.33% increase from 2023.
- Hims & Hers Health annual revenue for 2023 was $0.872B, a 65.49% increase from 2022.
- Hims & Hers Health annual revenue for 2022 was $0.527B, a 93.81% increase from 2021.
|
Hims & Hers Health Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $1,477 |
| 2023 | $872 |
| 2022 | $527 |
| 2021 | $272 |
| 2020 | $149 |
| 2019 | $83 |
| 2018 | |
|
Hims & Hers Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $599 |
| 2025-06-30 | $545 |
| 2025-03-31 | $586 |
| 2024-12-31 | $481 |
| 2024-09-30 | $402 |
| 2024-06-30 | $316 |
| 2024-03-31 | $278 |
| 2023-12-31 | $247 |
| 2023-09-30 | $227 |
| 2023-06-30 | $208 |
| 2023-03-31 | $191 |
| 2022-12-31 | $167 |
| 2022-09-30 | $145 |
| 2022-06-30 | $114 |
| 2022-03-31 | $101 |
| 2021-12-31 | $85 |
| 2021-09-30 | $74 |
| 2021-06-30 | $61 |
| 2021-03-31 | $52 |
| 2020-12-31 | $41 |
| 2020-09-30 | $41 |
| 2020-06-30 | $36 |
| 2020-03-31 | $30 |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $7.214B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.471B | 45.65 |
| Tempus AI (TEM) | United States | $11.790B | 0.00 |
| Doximity (DOCS) | United States | $8.244B | 33.95 |
| IRhythm Technologies (IRTC) | United States | $5.781B | 0.00 |
| Hinge Health (HNGE) | United States | $3.772B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.859B | 47.30 |
| Privia Health (PRVA) | United States | $2.834B | 177.23 |
| Heartflow (HTFL) | United States | $2.822B | 0.00 |
| 10x Genomics (TXG) | United States | $2.589B | 0.00 |
| Omnicell (OMCL) | United States | $2.277B | 46.55 |
| Azenta (AZTA) | United States | $1.744B | 71.55 |
| Enovis (ENOV) | United States | $1.697B | 8.91 |
| Schrodinger (SDGR) | United States | $1.355B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Phreesia (PHR) | United States | $1.039B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.021B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.861B | 0.00 |
| Talkspace (TALK) | United States | $0.666B | 134.00 |
| Standard BioTools (LAB) | United States | $0.592B | 0.00 |
| Claritev (CTEV) | United States | $0.478B | 0.00 |
| Evolent Health (EVH) | United States | $0.465B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.384B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.358B | 0.00 |
| Carlsmed (CARL) | United States | $0.337B | 0.00 |
| TruBridge (TBRG) | United States | $0.323B | 14.83 |
| Senseonics Holdings (SENS) | United States | $0.295B | 0.00 |
| CapsoVision (CV) | United States | $0.286B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.262B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.213B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.175B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.174B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.154B | 0.00 |
| CareCloud (CCLD) | United States | $0.129B | 7.09 |
| EUDA Health Holdings (EUDA) | Singapore | $0.087B | 0.00 |
| American Well (AMWL) | United States | $0.085B | 0.00 |
| Pulmonx (LUNG) | United States | $0.084B | 0.00 |
| Outset Medical (OM) | United States | $0.083B | 0.00 |
| HeartBeam (BEAT) | United States | $0.083B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.068B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.042B | 0.00 |
| 111 (YI) | China | $0.027B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.023B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |